CTI Science, Inc
CTI Science, Inc. is associated with EmeraMed Ltd, a biotechnology firm focused on developing Emeramide, a lipophilic blood-brain-barrier passing antioxidant. Emeramide is designed to combat oxidative stress by capturing free radicals and chelating heavy metals, thereby helping to restore mitochondrial function and improve overall health.
The company has completed a Phase 2a clinical trial for COPD, demonstrating the safety of Emeramide with no adverse effects reported, and is currently exploring its efficacy for various conditions, including Covid-19. Additionally, they are actively engaged in research to combat counterfeiting of Emeramide in the market.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Partial Data by Foursquare.